The Relay Thoracic Stent-Graft offers the following:
A wide range of stent diameters ( 22 – 46 mm) and lengths (100, 150, 200, 250 mm) to accommodate a variety of patient anatomies
Straight or tapered devices to accomodate different aortic shapes and configurations
Precise two step system for placing the stent in the aorta
Made of material that does not interfere with MRI procedures
About The Relay Clinical Trial
The Relay Thoracic Stent-Graft is considered experimental in the U.S. However, this device has been approved in Europe since 2005, and it has been used to successfully treat 2500 patients. Please read this information over closely, and discuss any questions you may have with your doctor. Only your doctor can decide if you are a good candidate for the Relay Thoracic Stent-Graft procedure.
How Relay Works
The Relay Thoracic Stent-Graft is implanted in the body using the Transport ® Delivery System. The animation below (no audio) illustrates how Relay Thoracic Stent-Graft is implanted in the aorta.
Who Can Participate in the Relay Thoracic Stent Graft Clinical Trial?
You may be considered for the Relay trial if you are:
Male or Female at least 18 years of age Diagnosed with descending TAA
Have anatomy that can accommodate the Relay Thoracic Stent-Graft
Consent to participate
Agree to comply with the follow-up schedule
You will not be considered for the Relay trial if you:
Have a condition other than an aneurysm in your aorta
Have less than one-year life expectancy
Have medical conditions that would interfere with the Relay procedure (e.g. Marfan’s Syndrome)
Are participating in other clinical studies
Manufacturer. Bolton Medical, Inc.,
799 International Parkway, Sunrise, FL 33325 +1-954-838-9699.
Caution: Investigational device. Limited by U.S. law to investigational use.
European Headquarters. Bolton Medical.
S.L.U. C/Newton, 18-24, 08635 Sant Esteve Sesrovires,
Barcelona, Spain +34-93-817-63-00